First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule
- 31 March 2005
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 47 (3) , 405-412
- https://doi.org/10.1016/j.lungcan.2004.08.012
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chemotherapy Options for the Elderly Patient with Advanced Non-Small Cell Lung CancerThe Oncologist, 2003
- Participation of Patients 65 Years of Age or Older in Cancer Clinical TrialsJournal of Clinical Oncology, 2003
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- Treatment of lung cancer in the elderly. Part I: non-small cell lung cancerLung Cancer, 2003
- Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.JNCI Journal of the National Cancer Institute, 2002
- Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized TrialJNCI Journal of the National Cancer Institute, 2002
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- The National Cancer Data Base report on lung cancerCancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995